Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Treasury Shares (2021 - 2025)

Neuroone Medical Technologies' Treasury Shares history spans 5 years, with the latest figure at $4085.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 67.23% year-over-year to $4085.0; the TTM value through Dec 2025 reached $4085.0, down 67.23%, while the annual FY2025 figure was $812696.0, 28.06% down from the prior year.
  • Treasury Shares reached $4085.0 in Q4 2025 per NMTC's latest filing, down from $812696.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.1 million in Q3 2024 to a low of $4.08 in Q2 2025.
  • Average Treasury Shares over 5 years is $214904.7, with a median of $26776.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: soared 3540.46% in 2022, then crashed 99.99% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $11384.0 in 2021, then skyrocketed by 3540.46% to $414430.0 in 2022, then crashed by 97.3% to $11176.0 in 2023, then increased by 11.55% to $12467.0 in 2024, then crashed by 67.23% to $4085.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Treasury Shares are $4085.0 (Q4 2025), $812696.0 (Q3 2025), and $4.08 (Q2 2025).